Multiplicity and the marginal benefits of bevacizumab in malignant solid tumours. [electronic resource]
Producer: 20200716Description: e791-e792 p. digitalISSN:- 1718-7729
No physical items for this record
Publication Type: Letter; Systematic Review
There are no comments on this title.
Log in to your account to post a comment.